Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.
Senseonics Holdings, Inc. has released expanded real-world evidence demonstrating sustained accuracy, performance and positive outcomes for its Eversense 365 continuous glucose monitoring system ...
Wearable and implantable biosensors have the potential to revolutionize health care by diagnosing, monitoring, and even ...
The Omnipod 5 with an iPhone [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced new clinical findings for its next-generation Omnipod 6 and fully closed-loop algorithm. The company ...